PMC:7344504 / 5219-5362 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"152","span":{"begin":34,"end":40},"obj":"Chemical"},{"id":"153","span":{"begin":127,"end":138},"obj":"Chemical"}],"attributes":[{"id":"A152","pred":"tao:has_database_id","subj":"152","obj":"MESH:D010100"},{"id":"A153","pred":"tao:has_database_id","subj":"153","obj":"MESH:D002443"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In the ICU, HFNO (high-flow nasal oxygen therapy) and selective digestive decontamination (SDD) were initiated, which includes ceftriaxone i.v."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T33","span":{"begin":34,"end":40},"obj":"Chemical"},{"id":"T34","span":{"begin":127,"end":138},"obj":"Chemical"}],"attributes":[{"id":"A33","pred":"chebi_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/CHEBI_25805"},{"id":"A34","pred":"chebi_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/CHEBI_29007"}],"text":"In the ICU, HFNO (high-flow nasal oxygen therapy) and selective digestive decontamination (SDD) were initiated, which includes ceftriaxone i.v."}

{"project":"LitCovid-sentences","denotations":[{"id":"T47","span":{"begin":0,"end":143},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In the ICU, HFNO (high-flow nasal oxygen therapy) and selective digestive decontamination (SDD) were initiated, which includes ceftriaxone i.v."}